Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
SHPH | US
-0.03
-2.10%
Healthcare
Drug Manufacturers-Specialty & Generic
30/06/2024
04/10/2024
1.17
1.18
1.20
1.14
Shuttle Pharmaceuticals Holdings Inc. a clinical stage pharmaceutical company develops novel therapies to cure cancers. It develops Ropidoxuridine an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas SP-1-161 an HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway for radiation sensitizing cancer cells and protecting normal cells; SP-2-225 a pre-clinical class IIb that effects on the regulation of the immune system; and SP-1-303 a pre-clinical selective Class I HDAC for the treatment of ER positive cancers. The company was founded in 2012 and is based in Rockville Maryland.
View LessNegative Momentum (Declining Price)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
High Debt to Equity (> 0.75)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
67.9%1 month
121.2%3 months
110.5%6 months
92.4%-
-
4.85
1.44
0.41
-0.67
-
-
-5.74M
3.43M
3.43M
-
-
-
-
-186.00
0.06
6.11
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.47
Range1M
2.17
Range3M
3.01
Rel. volume
0.01
Price X volume
16.99K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Sonoma Pharmaceuticals Inc | SNOA | Drug Manufacturers-Specialty & Generic | 2.78 | 3.72M | -5.44% | n/a | 8.44% |
PETROS PHARMACEUTICALS INC | PTPI | Drug Manufacturers-Specialty & Generic | 0.355 | 3.41M | 2.90% | n/a | 83.11% |
Avenue Therapeutics Inc | ATXI | Drug Manufacturers-Specialty & Generic | 2.075 | 2.97M | -14.26% | 0.07 | 0.00% |
Akanda Corp. Common Shares | AKAN | Drug Manufacturers-Specialty & Generic | 1.07 | 2.78M | 0.94% | n/a | -104.44% |
China SXT Pharmaceuticals Inc | SXTC | Drug Manufacturers-Specialty & Generic | 0.719 | 2.50M | -9.67% | n/a | 19.00% |
Bio-Path Holdings Inc | BPTH | Drug Manufacturers-Specialty & Generic | 0.871 | 2.22M | -1.28% | n/a | 4.26% |
PRFX | PRFX | Drug Manufacturers-Specialty & Generic | 0.6413 | 791.65K | 4.68% | n/a | -2.89% |
Sunshine Biopharma Inc. Warrant | SBFMW | Drug Manufacturers-Specialty & Generic | 0.103 | 0 | -0.96% | n/a | 2.46% |
Biofrontera Inc. Warrants | BFRIW | Drug Manufacturers-Specialty & Generic | 0.02 | 0 | n/a | 13.20% | |
Alvotech Warrant | ALVOW | Drug Manufacturers-Specialty & Generic | 2.98 | 0 | n/a | -196.14% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.3899 | 3.55M | -0.01% | n/a | 9.62% |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 0.4859 | 2.44M | -9.19% | n/a | 0.00% |
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.01 | 913.02K | -1.96% | n/a | -37.05% |
Blackstone/GSO Senior Floating Rate Term Fund | BSL | Textile Manufacturing | 14.17 | 0 | 0.78% | n/a |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -0.67 | 17.21 | Cheaper |
Ent. to Revenue | - | 334.38 | - |
PE Ratio | - | 26.92 | - |
Price to Book | 4.85 | 12.15 | Cheaper |
Dividend Yield | - | 2.77 | - |
Std. Deviation (3M) | 110.54 | 68.34 | Riskier |
Debt to Equity | 1.44 | -1.00 | Expensive |
Debt to Assets | 0.41 | 0.48 | Par |
Market Cap | 3.43M | 5.31B | Emerging |